BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6324993)

  • 1. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A; Cohen L; Glaubiger D
    Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A; Fuks Z; Gatt S; Glaubiger D
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin.
    Crescimanno M; D'Alessandro N; Armata MG; Toulmond S; Tapiero H
    Anticancer Res; 1991; 11(2):901-3. PubMed ID: 2064348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells.
    Gessner T; Vaughan LA; Beehler BC; Bartels CJ; Baker RM
    Cancer Res; 1990 Jul; 50(13):3921-7. PubMed ID: 2112982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
    Mimnaugh EG; Dusre L; Atwell J; Myers CE
    Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
    Ramu A; Glaubiger D; Weintraub H
    Cancer Treat Rep; 1984 Apr; 68(4):637-41. PubMed ID: 6713419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
    Nair S; Horton A; Leif RC; Krishan A
    Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
    Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.
    Begleiter A; Leith MK; McClarty G; Beenken S; Goldenberg GJ; Wright JA
    Cancer Res; 1988 Apr; 48(7):1727-35. PubMed ID: 3127038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin.
    Doroshow JH; Locker GY; Myers CE
    J Clin Invest; 1980 Jan; 65(1):128-35. PubMed ID: 7350193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.
    Sinha BK; Mimnaugh EG; Rajagopalan S; Myers CE
    Cancer Res; 1989 Jul; 49(14):3844-8. PubMed ID: 2544260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
    Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
    Ramu A; Glaubiger D; Fuks Z
    Cancer Res; 1984 Oct; 44(10):4392-5. PubMed ID: 6467200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S; Samy TS; Krishan A
    Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.